Machine learning-based unified models for predicting drug clearance from pharmacokinetic animal and study design variables
Fig 2
3D scatter plot representing the dataset (raw/imbalanced) used to develop the clearance/clearance/F(bioavailability) prediction model.
This plot contains a representative dataset used in the model development (A) clearance data distribution corresponding to drug and route of administration, (B) clearance data distribution corresponding to drug and animal.